Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
11.64 USD | -1.15% | +3.12% | +8.17% |
Apr. 18 | Viatris' Proposed Femoston, Duphaston UK Rights Divestment Being Considered, CMA Says | MT |
Apr. 18 | UK Regulator to Consider Undertakings for Theramex-Viatris Deal | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+8.17% | 13.99B | |
+33.65% | 664B | |
+29.61% | 567B | |
-6.86% | 354B | |
+19.65% | 330B | |
+4.32% | 286B | |
+13.58% | 234B | |
+5.44% | 199B | |
-9.78% | 196B | |
-4.59% | 148B |
- Stock Market
- Equities
- VTRS Stock
- News Viatris Inc.
- Barclays Adjusts Price Target on Viatris to $16 From $15, Keeps Overweight Rating